home / stock / brax:cc / brax:cc news

BRAX:CC News and Press, Braxia Scientific Corp. From 07/27/22

Stock Information
Company Name: Braxia Scientific Corp.
Stock Symbol: BRAX:CC
Market: CNQC
Menu
BRAX:CC BRAX:CC Quote BRAX:CC Short BRAX:CC News BRAX:CC Articles BRAX:CC Message Board
Get BRAX:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
BRAX:CC - Braxia Scientific Bolsters Leadership with Strategic Hires; Adds Chief Information Officer and Global Pharmaceutical Industry Leader as VP R&D and Growth

Braxia Scientific Bolsters Leadership with Strategic Hires; Adds Chief Information Officer and Global Pharmaceutical Industry Leader as VP R&D and Growth Braxia Scientific Bolsters Leadership with Strategic Hires; Adds Chief Information Officer and Global Pharmaceutical Indu...
BRAX:CC - Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond

Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neurops...

BRAX:CC - Braxia Scientific Expands Clinic Footprint in Canada Providing Greater Access to Network of Specialists Delivering Ketamine and Psilocybin Treatments for Depression and Related Mental Health Disorders

Braxia Scientific Expands Clinic Footprint in Canada Providing Greater Access to Network of Specialists Delivering Ketamine and Psilocybin Treatments for Depression and Related Mental Health Disorders Canada NewsWire TORONTO , June 15, 2022 /CNW/ - Braxia...

BRAX:CC - Braxia Scientific Presents Positive Preliminary Findings from Phase II Randomized, Multi-Dose Clinical Trial of Psilocybin-Assisted Therapy for Treatment Resistant Depression

Braxia Scientific Presents Positive Preliminary Findings from Phase II Randomized, Multi-Dose Clinical Trial of Psilocybin-Assisted Therapy for Treatment Resistant Depression Canada NewsWire TORONTO , June 2, 2022 /CNW Telbec/ - Braxia Scientific Corp. ...
BRAX:CC - Braxia Scientific Receives Health Canada Special Access Program Approval to Provide Psilocybin-Assisted Therapy for Depression in Ontario

Braxia Scientific Receives Health Canada Special Access Program Approval to Provide Psilocybin-Assisted Therapy for Depression in Ontario Canada NewsWire Health Canada approval is for a patient with the indication of Major Depressive Disorder, in the absence of ter...

BRAX:CC - Braxia Scientific to Present at H.C. Wainwright Global Investment Conference, Miami from May 24-26, 2022

Braxia Scientific to Present at H.C. Wainwright Global Investment Conference, Miami from May 24-26, 2022 Canada NewsWire TORONTO , May 19, 2022 /CNW/ - Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical r...

BRAX:CC - Braxia Scientific CEO to Speak at American Psychiatric Association Annual Meeting on Treatment Resistant Depression and Ketamine Guidelines Published in American Journal of Psychiatry

Braxia Scientific CEO to Speak at American Psychiatric Association Annual Meeting on Treatment Resistant Depression and Ketamine Guidelines Published in American Journal of Psychiatry Canada NewsWire TORONTO , May 18, 2022 /CNW/ - Braxia Scientific Corp. ...
BRAX:CC - Braxia Scientific CEO and CMO, Invited to Speak as Experts at the Ketamine and Related Compounds 2022 International Conference hosted by University of Oxford April 4-6

Braxia Scientific CEO and CMO, Invited to Speak as Experts at the Ketamine and Related Compounds 2022 International Conference hosted by University of Oxford April 4-6 Canada NewsWire TORONTO , April 1, 2022 /CNW/ - Braxia Scientific Corp. ("Braxia Scient...

Previous 10 Next 10